Merck and Company

MRK
Delayed Nyse - 10/11 10:04:26 pm
84.34USD
+0.69%
Prev.83.7600
Open84.3000
High85.4400
Low84.2600
Volume5 967 463
Company
Merck and Company specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (73.4%): for treating hypertension, osteoporosis, atherosclerosis, respiratory,...
Sector :
Pharmaceuticals - NEC
Calendar :
2019-10-29 Earnings Release
Trading Rating :
Investor Rating :
Latest news
10/10Germany's Merck KGaA Acquires FloDesign Sonics
DJ
10/09Massive jury award against J&J highlights risks of its legal strategy
RE
10/08MERCK AND : Cuts Emissions by 7%
DJ
10/08MERCK : Issues 2018/2019 Corporate Responsibility Report
BU
10/084D Pharma Enters Vaccine Collaboration With Merck & Co.
DJ
10/07GLOBAL MARKETS LIVE : HSBC, PayPal, AMS, GE…
10/04Clarityne Market to See Major Growth by 2025 | Merck & Co, Bayer, Perrigo, Apotex, Pfizer, Sandoz, Cadila Pharmaceutical
AQ
10/03MERCK AND : KEYTRUDA Now Approved as Monotherapy in China for First-Line Treatment of Certain Patients with Advanced Non-Small Cell Lung Cancer Whose Tumors Express PD-L1
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance86,986,986,6
Spread/Res.-3,0%-3,0%-2,6%
Spread/Supp.3,3%5,8%5,8%
Support81,679,779,7